Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Role of aGVHD Biomarkers on aGVHD Risks

NCT04284904 ·Status: COMPLETED

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

NCT02241018 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Graft-versus-host Disease Associated Myelosuppression

NCT02829216 ·Status: UNKNOWN

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

NCT05556928 ·Status: RECRUITING

Musculoskeletal Outcomes After Bone Marrow Transplant

NCT00558948 ·Status: COMPLETED

Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their Receptors

NCT01680055 ·Status: WITHDRAWN

The Indiana Myeloma Registry

NCT03616483 ·Status: RECRUITING

Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy

NCT02559830 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant

NCT03355235 ·Status: COMPLETED

Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room

NCT06286241 ·Status: NOT_YET_RECRUITING

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

NCT01408225 ·Status: RECRUITING

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

NCT00003538 ·Status: COMPLETED ·Phase: NA

Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease

NCT00092235 ·Status: RECRUITING

Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

NCT00001623 ·Status: COMPLETED ·Phase: NA

National Marrow Donor Program Long-Term Donor Follow-Up

NCT01362179 ·Status: COMPLETED

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

NCT00504803 ·Status: COMPLETED ·Phase: PHASE2

Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation

NCT00461955 ·Status: COMPLETED ·Phase: PHASE2

Role of Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and Mortality After Allogeneic Stem Cell Transplantation

NCT05755633 ·Status: COMPLETED

Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen (HLA) Compatible Donor in Ewing Sarcomas and Soft Tissues Sarcomas

NCT00998361 ·Status: UNKNOWN ·Phase: PHASE2

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

NCT00143884 ·Status: TERMINATED ·Phase: PHASE2

Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey

NCT04469985 ·Status: COMPLETED

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

NCT04167683 ·Status: ACTIVE_NOT_RECRUITING

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

NCT01758042 ·Status: COMPLETED ·Phase: NA

Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients

NCT02035189 ·Status: COMPLETED

Physical Characteristics of Retrieved Massive Allografts

NCT00160758 ·Status: COMPLETED